Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
The Razi Advantage comes from linking the entrepreneurial energy of their doctors to a brand that patients can trust. With the Razi Clinics brand, they offer a patient-centred approach to health care with a guarantee of affordability.
Meyer, an associate of London based multinational Vitabiotics Ltd.,is a rapidly growing Pharma Co. in India. Leadingpharmaceutical manufacturer, founded in 1982 .,in technical collaboration with OMEGA-MEYER Ltd Jersey( Br. Isles). H.O. based in THANE
Surya Healthcare is a subsidiary of Surya Pharmaceuticals Limited with widespread domestic and international operations. The force behind Surya Healthcare is its parent company Surya Pharmaceuticals Limited. It is uniquely positioned in the Pharmaceutical trade known for its competencies in API, formulation and contract manufacturing across different therapeutic segments serving both domestic and international clients.
Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Thiruvananthapuram is an Institute of National Importance established by an Act of the Indian Parliament and under the 2 administrative control of the Department of Science and Technology, Government of India.
Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.
Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.